Table 4: Pre-treatment and follow-up Scores on psychological measures, Mean (SD).
Outcome Measure | Pre-treatment | Follow up | t test | p value |
n = 8 | n = 8 | |||
PCL-5 Total | 52.55 (17.82) | 34.73 (13.55) | 4.43 | < 0.01* |
Intrusion symptoms | 12.55 (4.44) | 8.09 (3.08) | 4.15 | < 0.01* |
Avoidance symptoms | 5.45 (2.21) | 2.73 (2.33) | 3.41 | < 0.01* |
Cognition or mood symptoms | 18.82 (6.66) | 12.36 (7.05) | 3.46 | < 0.01* |
Arousal and reactivity symptoms | 15.73 (6.13) | 11.55 (3.61) | 3.37 | < 0.01* |
CES-D-10 | 19.45 (8.89) | 13.91 (6.40) | 2.82 | 0.02* |
GAD-7 | 13.45 (6.74) | 10.82 (4.77) | 1.72 | 0.12 |
DAR | 32.09 (20.62) | 23.45 (17.64) | 2.49 | 0.03* |
HGS-ECS Mean | 5.95 (2.19) | 4.53 (2.05) | 2.95 | 0.02* |
Global PSQI | 13.45 (4.39) | 12.73 (4.27) | 1.00 | 0.34 |
QoL-12 Mean | 5.37 (1.42) | 5.91 (1.48) | -1.45 | 0.18 |
IIP-32 Mean | 1.56 (0.61) | 1.32 (0.59) | 3.43 | < 0.01* |
*Statistically significant.
Note: SD: Standard Deviation; CES-D-10: Center for the Epidemiological Studies of Depression Short Form; PCL-5: PTSD Checklist for DSM-5; GAD-7: Generalized Anxiety Disorder-7; DAR: Dimensions of Anger Reactions; HGS-ECS: Holistic Grief Scale-Emotional Components Sub-scale; PSQI: Pittsburgh Sleep Quality Assessment; QoL-12: Subjective Quality of Life-12; IIP-32: Inventory of Interpersonal Problems-32.